Mark Korpics to Humans
This is a "connection" page, showing publications Mark Korpics has written about Humans.
Connection Strength
0.231
-
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases. J Clin Invest. 2023 05 15; 133(10).
Score: 0.029
-
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy. Int J Radiat Oncol Biol Phys. 2022 11 15; 114(4):645-654.
Score: 0.027
-
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis. Head Neck. 2022 07; 44(7):1528-1544.
Score: 0.026
-
A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):189-195.
Score: 0.023
-
Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments. J Appl Clin Med Phys. 2020 Mar; 21(3):184-191.
Score: 0.023
-
Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Cancer. 2017 Sep 15; 123(18):3524-3531.
Score: 0.019
-
Observer Evaluation of a Metal Artifact Reduction Algorithm Applied to Head and Neck Cone Beam Computed Tomographic Images. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):897-904.
Score: 0.018
-
Metal Artifact Reduction in Cone-Beam Computed Tomography for Head and Neck Radiotherapy. Technol Cancer Res Treat. 2016 12; 15(6):NP88-NP94.
Score: 0.017
-
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. Eur J Cancer. 2024 Sep; 209:114264.
Score: 0.008
-
Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials. Int J Radiat Oncol Biol Phys. 2024 Apr 01; 118(5):1519-1530.
Score: 0.007
-
Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC. Clin Lung Cancer. 2023 01; 24(1):60-71.
Score: 0.007
-
Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head Neck. 2021 09; 43(9):2589-2601.
Score: 0.006
-
Patterns of Care and Survival Outcomes for Odontogenic Cancers. Laryngoscope. 2021 05; 131(5):E1496-E1502.
Score: 0.006
-
Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop. Int J Radiat Oncol Biol Phys. 2020 11 01; 108(3):539-545.
Score: 0.006
-
Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):383-387.
Score: 0.005
-
Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer. Clin Oncol (R Coll Radiol). 2017 Jul; 29(7):429-435.
Score: 0.005